Have a personal or library account? Click to login
The Association between DNA Methylation Status and Epstein-Barr Virus Infection in Laryngeal Carcinomas Cover

The Association between DNA Methylation Status and Epstein-Barr Virus Infection in Laryngeal Carcinomas

Open Access
|Mar 2025

Figures & Tables

Figure 1:

The relationship between 5mC% and the expression levels of DNMTs in neoplastic tissues
The relationship between 5mC% and the expression levels of DNMTs in neoplastic tissues

Figure 2.

Methylation percentages of PDLIM4, DAPK1 and WIF 1 genes’ promoters in neoplastic (T) and peri-neoplastic (PT) laryngeal tissues
Methylation percentages of PDLIM4, DAPK1 and WIF 1 genes’ promoters in neoplastic (T) and peri-neoplastic (PT) laryngeal tissues

Figure 3.

Global (5-mC%) and local methylation profile (TSGs promoters methylation) in EBV-positive compared to EBV-negative laryngeal tumors
Global (5-mC%) and local methylation profile (TSGs promoters methylation) in EBV-positive compared to EBV-negative laryngeal tumors

Figure 4.

Investigated parameters in EBV positive (A) and EBV negative laryngeal tissue samples (B), according to T stage
Investigated parameters in EBV positive (A) and EBV negative laryngeal tissue samples (B), according to T stage

Sequences of primers and thermocycling conditions

Gene name [primers/probes reference]Primer/Probe sequencePCR technique Thermocycling conditions
β-globin [18]
  • Forward:5′-ACACAACTGTGTTCACTAGC-3′

  • Reverse:5′-CAACTTCATCCACGTTCACC-3′

  • PCR

  • 95°C/10 min

  • 40 cycles: 95°C/30 s, 55°C/50 s,

  • 72°C/1 min,

  • 72°C/7 min

BZLF1 [19]
  • Forward:5′-AAATTTAAGAGATCCTCGTGTAAAACATC-3′

  • Reverse:5′-CGCCTCCTGTTGAAGCAGAT-3′

  • Probe:5′-(6-FAM)-ATAATGGAGTCAACATCCAGGCTTGGGC-(TAMRA)-3′

  • qPCR

  • 50ºC/2 min, 95ºC/10 min

  • 40 cycles: 95ºC/15 s, 60ºC/1 min

LMP1 [19]
  • Forward:5′-CAGTCAGGCAAGCCTATGA-3′

  • Reverse:5′-CTGGTTCCGGTGGAGATGA-3′

  • Probe:5′-(6-FAM)-GTCATAGTAGCTTAGCTGAAC-(TAMRA)-3′

  • qPCR

  • 50ºC/2 min, 95ºC/10 min

  • 40 cycles: 95ºC/15 s, 60ºC/1 min

GAPDH [20]
  • Forward:5′-CCATCTTCCAGGAGCGAGATCCCT-3′

  • Reverse: 5′-TGAGCCCCAGCCTTCTTCATGGT-3′

  • qPCR

  • 96ºC/3 min

  • 40 cycles: 95ºC/10 s, 55ºC/30 s

PDLIM4 [21]
  • M-Forward:5′-TTTTAAAAGCGATTTTAAAGGGTC-3′

  • M-Reverse:5′-TTCGAAAAACTCTAAAAACCCG-3′

  • U-Forward:5′-TTTAAAAGTGATTTTAAAGGGTTGG-3′

  • U-Reverse:5′-CACTTCAAAAAACTCTAAAAACCCA-3′

  • qMS-PCR

  • 50ºC/2 min, 95ºC/10 min

  • 40 cycles: 95ºC/15 s, 58ºC/60 s

  • 50ºC/2 min, 95ºC/10 min

WIF1 [21]
  • M-Forward:5′-CGAGTTAAGGTTAGCGTTTGTTATC-3′

  • M-Reverse:5′-AAAATCCCTAATCAAAAAAAACATA-3′

  • U-Forward:5′-TTGAGTTAAGGTTAGTGTTTGTTATTG-3′

  • U-Reverse:5′-TAATAACTCCTATTCCTCCTCCAAC-3′

DAPK1 [this study]
  • M-Forward:5′-GGATAGTCGGATCGAGTTAACGTC-3′

  • M-Reverse:5′-CCCTCCCAACGCCGA-3′

  • U-Forward:5′-GGAGGATAGTTGGATTGAGTTAATGTT-3′

  • U-Reverse:5′-CAAATCCCTCCCAAACACCAA-3′

DNMT1 [20]
  • Forward:5′-GCGGTATACCCACCATGACA-3′

  • Reverse:5′-AGGCTTTGCCGGCTTCC-3′

  • qPCR

  • 96ºC/10 min

  • 40 cycles: 95ºC/10 s, 55ºC/30 s

DNMT3B [this study]
  • Forward:5′-CCAACAACACGCAACCAGTG-3′

  • Reverse:5′-CGTCTTCGAGTCTTGTTCTCGTA-3′

The correlation between the percent of global (5mC%) and local (TSGs promoters) methylation

ParameterPDLIM4WIF1DAPK1
Pearson r−0.4203−0.2904−0.3996
95% CI−0.6743 to −0.07755−0.5763 to 0.05871−0.6604 to −0.05269
P value (two-tailed)0.0186ns0.0259

Clinical characteristics of patients based on EBV infection status

Clinical characteristics EBV positive (n=11)EBV negative (n=13)
Age (years) 57–77 (median: 66)44–71 (median: 59)
SmokingYes5 (20.8%)13 (54.2%)
T stageT1-T23 (12.5%)9 (37.5%)
T3-T48 (33.3%)4 (16.6%)
N stageN0-N18 (33.3%)3 (12.5%)
N2-N33 (12.5%)10 (41.7%)
M stageM0-M111 (45.8%)13 (54.2%)

The characteristics of investigated group

Clinical characteristics Number of cases [n (%)]
Age (years)<65 / ≥6511 (45.8%) / 13 (54.2%)
SmokingYes19 (79.2%)
Lymph node metastasisYes / No11 (45.8%) / 13 (54.2)
T stageT1/T22/10 (8.3% / 41.7%)
T3/T49/3 (37.5% / 12.5%)
N stageN0/N15/6 (20.8% / 25%)
N2/N312/1 (50% / 4.2%)
M stageM0/M120/4 (83.3% / 16.7%)
DOI: https://doi.org/10.2478/rjim-2025-0005 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 152 - 162
Submitted on: Oct 16, 2024
Published on: Mar 21, 2025
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Irina Elisaveta Hotoboc, Alina Fudulu, Irina Huica, Iulia Virginia Iancu, Raluca Grigore, Șerban Vifor Gabriel Bertesteanu, Coralia Bleotu, Gabriela Anton, Anca Botezatu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.